Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Furosemide.
Acebutolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Acebutolol.
Aceclofenac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Aceclofenac.
Advertisement
Acemetacin
Furosemide may increase the excretion rate of Acemetacin which could result in a lower serum level and potentially a reduction in efficacy.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Furosemide.
Acetyl salicylate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Acetylsalicylic acid.
Advertisement
Acetyldigitoxin
The risk or severity of adverse effects can be increased when Furosemide is combined with Acetyldigitoxin.
Aclarubicin
The serum concentration of Aclarubicin can be increased when it is combined with Furosemide.
Adapalene
The therapeutic efficacy of Furosemide can be decreased when used in combination with Adapalene.
Advertisement
Albuterol
Salbutamol may increase the hypokalemic activities of Furosemide.
Alclometasone
Alclometasone may increase the hypokalemic activities of Furosemide.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Furosemide.
Aldosterone
Aldosterone may increase the hypokalemic activities of Furosemide.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Furosemide.
Aliskiren
The serum concentration of Furosemide can be decreased when it is combined with Aliskiren.
Allopurinol
The risk or severity of adverse effects can be increased when Furosemide is combined with Allopurinol.
Alminoprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Alminoprofen.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Furosemide.
Aloxiprin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Aloxiprin.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Furosemide.
Amcinonide
Amcinonide may increase the hypokalemic activities of Furosemide.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Furosemide.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Furosemide.
Amikacin
The serum concentration of Amikacin can be increased when it is combined with Furosemide.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Furosemide.
Aminosalicylic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Aminosalicylic Acid.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Furosemide.
Amlodipine
The risk or severity of adverse effects can be increased when Amlodipine is combined with Furosemide.
Amobarbital
Amobarbital may increase the hypotensive activities of Furosemide.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Furosemide.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Furosemide.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Furosemide is combined with Amyl Nitrite.
Androstenedione
Androstenedione may increase the hypokalemic activities of Furosemide.
Antipyrine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Antipyrine.
Apazone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Azapropazone.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Furosemide.
Apraclonidine
The risk or severity of adverse effects can be increased when Furosemide is combined with Apraclonidine.
Apremilast
The therapeutic efficacy of Furosemide can be decreased when used in combination with Apremilast.
Arbekacin
The serum concentration of Arbekacin can be increased when it is combined with Furosemide.
Arbutamine
Arbutamine may increase the hypokalemic activities of Furosemide.
Arformoterol
Arformoterol may increase the hypokalemic activities of Furosemide.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Furosemide.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Furosemide.
Aspirin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
The risk or severity of adverse effects can be increased when Atenolol is combined with Furosemide.
Atracurium
Furosemide may decrease the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Furosemide may decrease the neuromuscular blocking activities of Atracurium besylate.
Azelastine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Furosemide is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Furosemide is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Furosemide is combined with Azilsartan medoxomil.
Balsalazide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Balsalazide.
Bambuterol
Bambuterol may increase the hypokalemic activities of Furosemide.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Furosemide.
Barbital
Barbital may increase the hypotensive activities of Furosemide.
Beclomethasone Dipropionate
Beclomethasone dipropionate may increase the hypokalemic activities of Furosemide.
Benazepril
Furosemide may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Furosemide.
Benzydamine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Benzydamine.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Furosemide.
Betamethasone
Betamethasone may increase the hypokalemic activities of Furosemide.
Betaxolol
The risk or severity of adverse effects can be increased when Betaxolol is combined with Furosemide.
Bisoprolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Furosemide.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Furosemide.
Bretylium
The risk or severity of adverse effects can be increased when Furosemide is combined with Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Brimonidine is combined with Furosemide.
Bromfenac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Bromfenac.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Furosemide.
Budesonide
Budesonide may increase the hypokalemic activities of Furosemide.
Bufexamac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Bufexamac.
Bumetanide
The risk or severity of adverse effects can be increased when Furosemide is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Furosemide.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Furosemide.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Furosemide.
Canagliflozin
The risk or severity of hypotension can be increased when Canagliflozin is combined with Furosemide.
Canagliflozin Anhydrous
The risk or severity of hypotension can be increased when Canagliflozin is combined with Furosemide.
Candesartan Cilexetil
The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Furosemide.
Captopril
Furosemide may increase the hypotensive activities of Captopril.
Carprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Carprofen.
Carteolol
The risk or severity of adverse effects can be increased when Carteolol is combined with Furosemide.
Carvedilol
The risk or severity of adverse effects can be increased when Furosemide is combined with Carvedilol.
Celecoxib
The therapeutic efficacy of Furosemide can be decreased when used in combination with Celecoxib.
Celiprolol
Celiprolol may increase the hypokalemic activities of Furosemide.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Furosemide is combined with Chloral hydrate.
Chloroquine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Chloroquine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Furosemide is combined with Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Furosemide.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Furosemide.
Chlorthalidone
The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Furosemide.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Furosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Choline magnesium trisalicylate.
Ciclesonide
Ciclesonide may increase the hypokalemic activities of Furosemide.
Cilazapril
Furosemide may increase the hypotensive activities of Cilazapril.
Cisatracurium
Furosemide may decrease the neuromuscular blocking activities of Cisatracurium besylate.
Cisplatin
The risk or severity of ototoxicity and nephrotoxicity can be increased when Furosemide is combined with Cisplatin.
Clenbuterol
Clenbuterol may increase the hypokalemic activities of Furosemide.
Clevidipine
The risk or severity of adverse effects can be increased when Furosemide is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Furosemide is combined with Clevidipine.
Clobetasol
Clobetasol may increase the hypokalemic activities of Furosemide.
Clobetasol Propionate
Clobetasol propionate may increase the hypokalemic activities of Furosemide.
Clobetasone
Clobetasone may increase the hypokalemic activities of Furosemide.
Clocortolone
Clocortolone may increase the hypokalemic activities of Furosemide.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Furosemide.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Furosemide.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Furosemide.
Clonixin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Clonixin.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Furosemide.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Furosemide.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Furosemide.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Furosemide.
Colesevelam
Colesevelam can cause a decrease in the absorption of Furosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Furosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Furosemide.
Cortisone Acetate
Cortisone acetate may increase the hypokalemic activities of Furosemide.
Curcumin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Curcumin.
Cyclosporine
The risk or severity of adverse effects can be increased when Cyclosporine is combined with Furosemide.
Dapagliflozin
The risk or severity of adverse effects can be increased when Furosemide is combined with Dapagliflozin.
Daunorubicin
The serum concentration of Daunorubicin can be increased when it is combined with Furosemide.
Deflazacort
Deflazacort may increase the hypokalemic activities of Furosemide.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Furosemide.
Deslanoside
The risk or severity of adverse effects can be increased when Furosemide is combined with Deslanoside.
Desonide
Desonide may increase the hypokalemic activities of Furosemide.
Desoximetasone
Desoximetasone may increase the hypokalemic activities of Furosemide.
Desoxycorticosterone acetate
Desoxycorticosterone acetate may increase the hypokalemic activities of Furosemide.
Desoxycorticosterone Pivalate
Desoxycorticosterone Pivalate may increase the hypokalemic activities of Furosemide.
Dexamethasone
Dexamethasone may increase the hypokalemic activities of Furosemide.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Furosemide.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Furosemide.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Furosemide.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Furosemide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Furosemide is combined with Diclofenamide.
Diclofenac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Diclofenac.
Diflorasone
Diflorasone may increase the hypokalemic activities of Furosemide.
Diflucortolone
Difluocortolone may increase the hypokalemic activities of Furosemide.
Diflunisal
The therapeutic efficacy of Furosemide can be decreased when used in combination with Diflunisal.
Difluprednate
Difluprednate may increase the hypokalemic activities of Furosemide.
Digitoxin
The risk or severity of adverse effects can be increased when Furosemide is combined with Digitoxin.
Digoxin
The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Furosemide.
Dihydrostreptomycin
The serum concentration of Dihydrostreptomycin can be increased when it is combined with Furosemide.
Diltiazem
The risk or severity of adverse effects can be increased when Diltiazem is combined with Furosemide.
Dinutuximab
The risk or severity of adverse effects can be increased when Furosemide is combined with Dinutuximab.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Furosemide.
Dipivefrin
Dipivefrin may increase the hypokalemic activities of Furosemide.
Dipyridamole
The risk or severity of adverse effects can be increased when Furosemide is combined with Dipyridamole.
Dipyrone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Metamizole.
Dobutamine
Dobutamine may increase the hypokalemic activities of Furosemide.
Dofetilide
The risk or severity of QTc prolongation, torsade de pointes, hypokalemia, hypomagnesemia, and cardiac arrest can be increased when Furosemide is combined with Dofetilide.
Doxacurium Chloride
Furosemide may decrease the neuromuscular blocking activities of Doxacurium chloride.
Doxazosin
The risk or severity of adverse effects can be increased when Doxazosin is combined with Furosemide.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Furosemide.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Furosemide.
Droxicam
The therapeutic efficacy of Furosemide can be decreased when used in combination with Droxicam.
Droxidopa
Droxidopa may increase the hypokalemic activities of Furosemide.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Furosemide.
Duloxetine
Furosemide may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Furosemide is combined with Empagliflozin.
Enalapril
Furosemide may increase the hypotensive activities of Enalapril.
Enalaprilat
Furosemide may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Furosemide may increase the hypotensive activities of Enalaprilat.
Epinephrine
Epinephrine may increase the hypokalemic activities of Furosemide.
Epirubicin
The serum concentration of Epirubicin can be increased when it is combined with Furosemide.
Eplerenone
The risk or severity of adverse effects can be increased when Furosemide is combined with Eplerenone.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Furosemide.
Eprosartan
The risk or severity of adverse effects can be increased when Furosemide is combined with Eprosartan.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Furosemide.
Estrone
Estrone may increase the hypokalemic activities of Furosemide.
Etanercept
The therapeutic efficacy of Furosemide can be decreased when used in combination with Etanercept.
Ethacrynate
Furosemide may increase the ototoxic activities of Etacrynic acid.
Ethacrynic Acid
Furosemide may increase the ototoxic activities of Etacrynic acid.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Furosemide.
Etodolac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Etodolac.
Etofenamate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Etofenamate.
Etoricoxib
The therapeutic efficacy of Furosemide can be decreased when used in combination with Etoricoxib.
Evening primrose oil
The therapeutic efficacy of Furosemide can be decreased when used in combination with Evening primrose oil.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Furosemide.
Felbinac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Felbinac.
Felodipine
The risk or severity of adverse effects can be increased when Furosemide is combined with Felodipine.
Fenbufen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Fenbufen.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Furosemide.
Fenoprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Fenoprofen.
Fenoterol
Fenoterol may increase the hypokalemic activities of Furosemide.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Furosemide.
Ferulic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ferulic acid.
Floctafenine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Floctafenine.
Fludrocortisone
Fludrocortisone may increase the hypokalemic activities of Furosemide.
Flumethasone
Flumethasone may increase the hypokalemic activities of Furosemide.
Flunisolide
Flunisolide may increase the hypokalemic activities of Furosemide.
Flunisolide Anhydrous (obsolete)
Flunisolide may increase the hypokalemic activities of Furosemide.
Fluocinolone Acetonide
Fluocinolone Acetonide may increase the hypokalemic activities of Furosemide.
Fluocinonide
Fluocinonide may increase the hypokalemic activities of Furosemide.
Fluocortolone
Fluocortolone may increase the hypokalemic activities of Furosemide.
Fluorometholone
Fluorometholone may increase the hypokalemic activities of Furosemide.
FLUPREDNIDENE
Fluprednidene may increase the hypokalemic activities of Furosemide.
Fluprednisolone
Fluprednisolone may increase the hypokalemic activities of Furosemide.
Flurandrenolide
Flurandrenolide may increase the hypokalemic activities of Furosemide.
Flurbiprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Flurbiprofen.
Fluticasone Furoate
Fluticasone furoate may increase the hypokalemic activities of Furosemide.
Fluticasone propionate
Fluticasone propionate may increase the hypokalemic activities of Furosemide.
Formestane
Formestane may increase the hypokalemic activities of Furosemide.
Formoterol
Formoterol may increase the hypokalemic activities of Furosemide.
Foscarnet
Furosemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Fosinopril
Furosemide may increase the hypotensive activities of Fosinopril.
Fosphenytoin
Fosphenytoin may decrease the diuretic activities of Furosemide.
Framycetin
The serum concentration of Framycetin can be increased when it is combined with Furosemide.
Gallamine Triethiodide
Furosemide may decrease the neuromuscular blocking activities of Gallamine Triethiodide.
Gentamicin
The serum concentration of Gentamicin can be increased when it is combined with Furosemide.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Furosemide.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Furosemide.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Furosemide.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Furosemide.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Furosemide.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Furosemide.
Guanfacine
The risk or severity of adverse effects can be increased when Furosemide is combined with Guanfacine.
Halcinonide
Halcinonide may increase the hypokalemic activities of Furosemide.
Halobetasol
Ulobetasol may increase the hypokalemic activities of Furosemide.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Furosemide.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Furosemide.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Furosemide.
Hyaluronidase
The therapeutic efficacy of Furosemide can be decreased when used in combination with Hyaluronidase.
Hyaluronidase, Ovine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Hyaluronidase.
Hydralazine
The risk or severity of adverse effects can be increased when Furosemide is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Furosemide is combined with Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Furosemide.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Furosemide.
Hydrocortisone
Hydrocortisone may increase the hypokalemic activities of Furosemide.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Furosemide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Furosemide.
Ibuprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.
Icatibant
The therapeutic efficacy of Furosemide can be decreased when used in combination with Icatibant.
Idarubicin
The serum concentration of Idarubicin can be increased when it is combined with Furosemide.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Furosemide.
Imidapril
Furosemide may increase the hypotensive activities of Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Furosemide.
Indacaterol
Indacaterol may increase the hypokalemic activities of Furosemide.
Indapamide
The risk or severity of adverse effects can be increased when Furosemide is combined with Indapamide.
Indobufen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Indobufen.
Indomethacin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.
Indoramin
The risk or severity of adverse effects can be increased when Indoramin is combined with Furosemide.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Furosemide.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Furosemide.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Furosemide.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Furosemide.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Furosemide.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Furosemide.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Furosemide.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Furosemide.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Furosemide.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Furosemide.
Irbesartan
The risk or severity of adverse effects can be increased when Furosemide is combined with Irbesartan.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Furosemide.
Isoetharine
Isoetarine may increase the hypokalemic activities of Furosemide.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Furosemide.
Isoproterenol
Isoprenaline may increase the hypokalemic activities of Furosemide.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Furosemide is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Furosemide is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Furosemide is combined with Isoxsuprine.
Isradipine
The risk or severity of adverse effects can be increased when Isradipine is combined with Furosemide.
Ivabradine
Furosemide may increase the arrhythmogenic activities of Ivabradine.
Kanamycin
The serum concentration of Kanamycin can be increased when it is combined with Furosemide.
kanamycin A
The serum concentration of Kanamycin can be increased when it is combined with Furosemide.
Kebuzone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Kebuzone.
Ketoprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ketoprofen.
Ketorolac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ketorolac.
Labetalol
The risk or severity of adverse effects can be increased when Labetalol is combined with Furosemide.
Lacidipine
Furosemide may increase the hypotensive activities of Lacidipine.
Leflunomide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Leflunomide.
Lercanidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Furosemide.
Levalbuterol
Levosalbutamol may increase the hypokalemic activities of Furosemide.
Levobunolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Furosemide.
Levodopa
Furosemide may increase the orthostatic hypotensive activities of Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Furosemide.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Furosemide.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Furosemide.
Licorice Allergenic Extract
The risk or severity of hypokalemia can be increased when Licorice is combined with Furosemide.
Limonene, (+)-
The therapeutic efficacy of Furosemide can be decreased when used in combination with (4R)-limonene.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Furosemide.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Furosemide.
Lisinopril
Furosemide may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Furosemide may increase the hypotensive activities of Lisinopril.
Lithium
The serum concentration of Lithium can be decreased when it is combined with Furosemide.
Lithium Cation
The serum concentration of Lithium can be decreased when it is combined with Furosemide.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Furosemide.
Lornoxicam
The therapeutic efficacy of Furosemide can be decreased when used in combination with Lornoxicam.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Furosemide.
Loteprednol
Loteprednol may increase the hypokalemic activities of Furosemide.
Loxoprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Loxoprofen.
Magnesium Salicylate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Magnesium salicylate.
Mannitol
The risk or severity of adverse effects can be increased when Furosemide is combined with Mannitol.
Masoprocol
The therapeutic efficacy of Furosemide can be decreased when used in combination with Masoprocol.
Mecamylamine
The risk or severity of adverse effects can be increased when Furosemide is combined with Mecamylamine.
Meclofenamate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Meclofenamic acid.
Meclofenamic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Meclofenamic acid.
Medrysone
Medrysone may increase the hypokalemic activities of Furosemide.
Mefenamic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Mefenamic acid.
Meloxicam
The therapeutic efficacy of Furosemide can be decreased when used in combination with Meloxicam.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Furosemide.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Furosemide.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Furosemide.
Mesalamine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Mesalazine.
Metaproterenol
Orciprenaline may increase the hypokalemic activities of Furosemide.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Furosemide.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Furosemide.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Furosemide.
Methazolamide
The risk or severity of adverse effects can be increased when Furosemide is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Furosemide.
Methotrexate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Methotrexate.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Furosemide.
Methyl Salicylate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Methyl salicylate.
Methyldopa
The risk or severity of adverse effects can be increased when Furosemide is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Furosemide is combined with Methyldopa.
Methylprednisolone
Methylprednisolone may increase the hypokalemic activities of Furosemide.
Metipranolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Metipranolol.
Metocurine
Furosemide may decrease the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Furosemide may decrease the neuromuscular blocking activities of Metocurine Iodide.
Metolazone
The risk or severity of adverse effects can be increased when Metolazone is combined with Furosemide.
Metoprolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Furosemide.
Metrizamide
The serum concentration of Metrizamide can be increased when it is combined with Furosemide.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Furosemide.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Furosemide.
Minoxidil
The risk or severity of adverse effects can be increased when Minoxidil is combined with Furosemide.
Mivacurium
Furosemide may decrease the neuromuscular blocking activities of Mivacurium.
Moexipril
Furosemide may increase the hypotensive activities of Moexipril.
Mometasone
Mometasone may increase the hypokalemic activities of Furosemide.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Furosemide.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Furosemide.
MYCOPHENOLATE
The therapeutic efficacy of Furosemide can be decreased when used in combination with Mycophenolic acid.
Mycophenolate Mofetil
The therapeutic efficacy of Furosemide can be decreased when used in combination with Mycophenolate mofetil.
Mycophenolic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Mycophenolic acid.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Furosemide.
Nabumetone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Nabumetone.
Nadolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Nadolol.
Naftifine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Naftifine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Furosemide.
Naproxen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Naproxen.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Furosemide.
Nebivolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Nebivolol.
Neomycin
The serum concentration of Neomycin can be increased when it is combined with Furosemide.
Nepafenac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Nepafenac.
Nesiritide
The risk or severity of adverse effects can be increased when Furosemide is combined with Nesiritide.
Netilmicin
The serum concentration of Netilmicin can be increased when it is combined with Furosemide.
Nicardipine
The risk or severity of adverse effects can be increased when Nicardipine is combined with Furosemide.
Nicorandil
Nicorandil may increase the hypotensive activities of Furosemide.
Nifedipine
The risk or severity of adverse effects can be increased when Furosemide is combined with Nifedipine.
Niflumic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Niflumic Acid.
Nilvadipine
The risk or severity of adverse effects can be increased when Nilvadipine is combined with Furosemide.
Nimesulide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Nimesulide.
Nimodipine
The risk or severity of adverse effects can be increased when Nimodipine is combined with Furosemide.
Nisoldipine
The risk or severity of adverse effects can be increased when Nisoldipine is combined with Furosemide.
Nitrendipine
The risk or severity of adverse effects can be increased when Nitrendipine is combined with Furosemide.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Furosemide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Furosemide is combined with Nitroglycerin.
Nitroprusside
The risk or severity of adverse effects can be increased when Nitroprusside is combined with Furosemide.
Norepinephrine
Norepinephrine may increase the hypokalemic activities of Furosemide.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Furosemide.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Furosemide.
Oenothera biennis seed extract
The therapeutic efficacy of Furosemide can be decreased when used in combination with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Furosemide.
Olodaterol
Olodaterol may increase the hypokalemic activities of Furosemide.
Olopatadine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Olopatadine.
Olsalazine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Olsalazine.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Furosemide.
Ouabain
The risk or severity of adverse effects can be increased when Furosemide is combined with Ouabain.
Ovine Digoxin Immune Fab
The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin Immune Fab (Ovine).
Oxaprozin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Oxaprozin.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Furosemide.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Furosemide.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Furosemide.
Oxyphenbutazone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Oxyphenbutazone.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Furosemide.
Pancuronium
Furosemide may decrease the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Furosemide may decrease the neuromuscular blocking activities of Pancuronium.
Papaverine
The risk or severity of adverse effects can be increased when Furosemide is combined with Papaverine.
Paramethasone
Paramethasone may increase the hypokalemic activities of Furosemide.
Parecoxib
The therapeutic efficacy of Furosemide can be decreased when used in combination with Parecoxib.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Furosemide.
Paromomycin
The serum concentration of Paromomycin can be increased when it is combined with Furosemide.
Parthenolide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Parthenolide.
Penbutolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Penbutolol.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Furosemide.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Furosemide.
Perindopril
Furosemide may increase the hypotensive activities of Perindopril.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Furosemide.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Furosemide.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Furosemide.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Furosemide.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Furosemide.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Furosemide.
Phenylbutazone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Phenylbutazone.
Phenylpropanolamine
Phenylpropanolamine may increase the hypokalemic activities of Furosemide.
Phenytoin
Phenytoin may decrease the diuretic activities of Furosemide.
Pimecrolimus
The therapeutic efficacy of Furosemide can be decreased when used in combination with Pimecrolimus.
Pindolol
The risk or severity of adverse effects can be increased when Furosemide is combined with Pindolol.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Furosemide.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Furosemide.
Pipecuronium
Furosemide may decrease the neuromuscular blocking activities of Pipecuronium.
Pirarubicin
The serum concentration of Pirarubicin can be increased when it is combined with Furosemide.
Pirbuterol
Pirbuterol may increase the hypokalemic activities of Furosemide.
Pirfenidone
The therapeutic efficacy of Furosemide can be decreased when used in combination with Pirfenidone.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Furosemide.
Piroxicam
The therapeutic efficacy of Furosemide can be decreased when used in combination with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Piroxicam.
Plicamycin
The serum concentration of Plicamycin can be increased when it is combined with Furosemide.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Furosemide.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Furosemide.
Prasterone
Prasterone may increase the hypokalemic activities of Furosemide.
Prazosin
The risk or severity of adverse effects can be increased when Prazosin is combined with Furosemide.
Prednicarbate
Prednicarbate may increase the hypokalemic activities of Furosemide.
Prednisolone
Prednisolone may increase the hypokalemic activities of Furosemide.
Prednisone
Prednisone may increase the hypokalemic activities of Furosemide.
Pregnenolone
Pregnenolone may increase the hypokalemic activities of Furosemide.
Primidone
Primidone may increase the hypotensive activities of Furosemide.
Probenecid
The risk or severity of adverse effects can be increased when Probenecid is combined with Furosemide.
Procaterol
Procaterol may increase the hypokalemic activities of Furosemide.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Furosemide.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Furosemide.
Propranolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Furosemide.
Proscillaridin
The risk or severity of adverse effects can be increased when Furosemide is combined with Proscillaridin.
Pyrantel
Furosemide may decrease the neuromuscular blocking activities of Pyrantel.
Quetiapine
The risk or severity of adverse effects can be increased when Furosemide is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Furosemide is combined with Quetiapine.
Quinapril
Furosemide may increase the hypotensive activities of Quinapril.
Ramipril
Furosemide may increase the hypotensive activities of Ramipril.
Rapacuronium
Furosemide may decrease the neuromuscular blocking activities of Rapacuronium.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Furosemide.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Furosemide.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Furosemide.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Furosemide.
Rescinnamine
Furosemide may increase the hypotensive activities of Rescinnamine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Furosemide.
Resveratrol
The therapeutic efficacy of Furosemide can be decreased when used in combination with Resveratrol.
Rimexolone
Rimexolone may increase the hypokalemic activities of Furosemide.
Riociguat
The risk or severity of adverse effects can be increased when Furosemide is combined with Riociguat.
Risperidone
The risk or severity of adverse effects can be increased when Furosemide is combined with Risperidone.
Ritodrine
Ritodrine may increase the hypokalemic activities of Furosemide.
Rocuronium
Furosemide may decrease the neuromuscular blocking activities of Rocuronium.
Rofecoxib
The therapeutic efficacy of Furosemide can be decreased when used in combination with Rofecoxib.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Furosemide.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Furosemide.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Furosemide.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Furosemide.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Furosemide.
Salicylamide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Salicylamide.
Salicylic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Salicylic acid.
Salmeterol
Salmeterol may increase the hypokalemic activities of Furosemide.
Salsalate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Salsalate.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Furosemide.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Furosemide.
Secobarbital
Secobarbital may increase the hypotensive activities of Furosemide.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Furosemide.
Serratiopeptidase
The therapeutic efficacy of Furosemide can be decreased when used in combination with Serrapeptase.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Furosemide.
Sisomicin
The serum concentration of Sisomicin can be increased when it is combined with Furosemide.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Furosemide.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Furosemide.
Sodium Phosphate
Furosemide may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Furosemide may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Furosemide may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Furosemide.
Spectinomycin
The serum concentration of Spectinomycin can be increased when it is combined with Furosemide.
Spirapril
Furosemide may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Furosemide.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Furosemide.
Streptomycin
The serum concentration of Streptomycin can be increased when it is combined with Furosemide.
Streptozocin
The serum concentration of Streptozocin can be increased when it is combined with Furosemide.
Succinylcholine
Furosemide may decrease the neuromuscular blocking activities of Succinylcholine.
Sucralfate
The serum concentration of Furosemide can be decreased when it is combined with Sucralfate.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Furosemide.
Sulfasalazine
The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulfasalazine.
Sulindac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.
Sulpiride
The risk or severity of adverse effects can be increased when Furosemide is combined with Sulpiride.
Suprofen
The therapeutic efficacy of Furosemide can be decreased when used in combination with Suprofen.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Furosemide.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Furosemide.
Telmisartan
The risk or severity of adverse effects can be increased when Furosemide is combined with Telmisartan.
Tenoxicam
The therapeutic efficacy of Furosemide can be decreased when used in combination with Tenoxicam.
Terazosin
The risk or severity of adverse effects can be increased when Furosemide is combined with Terazosin.
Terbutaline
Terbutaline may increase the hypokalemic activities of Furosemide.
Terbutaline Sulfate
Terbutaline may increase the hypokalemic activities of Furosemide.
Teriflunomide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Teriflunomide.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Furosemide.
Thiamylal
Thiamylal may increase the hypotensive activities of Furosemide.
Thiopental
Thiopental may increase the hypotensive activities of Furosemide.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Furosemide.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Furosemide.
Tiaprofenic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Tiaprofenic acid.
Timolol
The risk or severity of adverse effects can be increased when Timolol is combined with Furosemide.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Timolol is combined with Furosemide.
Tixocortol
Tixocortol may increase the hypokalemic activities of Furosemide.
Tizanidine
The risk or severity of adverse effects can be increased when Furosemide is combined with Tizanidine.
Tobramycin
The serum concentration of Tobramycin can be increased when it is combined with Furosemide.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Furosemide.
Tolazoline
The risk or severity of adverse effects can be increased when Tolazoline is combined with Furosemide.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Furosemide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Furosemide.
Tolfenamic Acid
The therapeutic efficacy of Furosemide can be decreased when used in combination with Tolfenamic Acid.
Tolmetin
The therapeutic efficacy of Furosemide can be decreased when used in combination with Tolmetin.
Topiramate
The risk or severity of hypokalemia can be increased when Furosemide is combined with Topiramate.
Torsemide
The risk or severity of adverse effects can be increased when Torasemide is combined with Furosemide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Furosemide.
Trandolapril
Furosemide may increase the hypotensive activities of Trandolapril.
Tranilast
The therapeutic efficacy of Furosemide can be decreased when used in combination with Tranilast.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Furosemide.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Furosemide.
Triamcinolone
Triamcinolone may increase the hypokalemic activities of Furosemide.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Furosemide.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Furosemide.
Trolamine Salicylate
The therapeutic efficacy of Furosemide can be decreased when used in combination with Trolamine salicylate.
Tubocurarine
Furosemide may decrease the neuromuscular blocking activities of Tubocurarine.
Valdecoxib
The therapeutic efficacy of Furosemide can be decreased when used in combination with Valdecoxib.
Valrubicin
The serum concentration of Valrubicin can be increased when it is combined with Furosemide.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Furosemide.
Vecuronium
Furosemide may decrease the neuromuscular blocking activities of Vecuronium.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Furosemide.
Vilanterol
Vilanterol may increase the hypokalemic activities of Furosemide.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Furosemide.
Zileuton
The therapeutic efficacy of Furosemide can be decreased when used in combination with Zileuton.
Zofenopril
Furosemide may increase the hypotensive activities of Zofenopril.
Zomepirac
The therapeutic efficacy of Furosemide can be decreased when used in combination with Zomepirac.
